HK1098352A1 - Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis - Google Patents

Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis

Info

Publication number
HK1098352A1
HK1098352A1 HK07104747.1A HK07104747A HK1098352A1 HK 1098352 A1 HK1098352 A1 HK 1098352A1 HK 07104747 A HK07104747 A HK 07104747A HK 1098352 A1 HK1098352 A1 HK 1098352A1
Authority
HK
Hong Kong
Prior art keywords
zinc
treatment
multiple sclerosis
pharmaceutical composition
hyaluronate complex
Prior art date
Application number
HK07104747.1A
Other languages
English (en)
Inventor
G T Balogh
J Illes
A Boros
G Forrai
A Szekely
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of HK1098352A1 publication Critical patent/HK1098352A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK07104747.1A 2003-11-20 2007-05-04 Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis HK1098352A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0303779A HUP0303779A2 (en) 2003-11-20 2003-11-20 Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
PCT/HU2004/000107 WO2005049047A1 (en) 2003-11-20 2004-11-18 Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
HK1098352A1 true HK1098352A1 (en) 2007-07-20

Family

ID=90001707

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07104747.1A HK1098352A1 (en) 2003-11-20 2007-05-04 Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis

Country Status (20)

Country Link
US (1) US20070123488A1 (uk)
EP (1) EP1699468B1 (uk)
JP (1) JP4778908B2 (uk)
CN (1) CN1882352B (uk)
AT (1) ATE359800T1 (uk)
CY (1) CY1106617T1 (uk)
DE (1) DE602004006024T2 (uk)
DK (1) DK1699468T3 (uk)
EA (1) EA009209B1 (uk)
ES (1) ES2286698T3 (uk)
HK (1) HK1098352A1 (uk)
HR (1) HRP20070291T3 (uk)
HU (1) HUP0303779A2 (uk)
NO (1) NO336121B1 (uk)
PL (1) PL1699468T3 (uk)
PT (1) PT1699468E (uk)
RS (2) RS50523B (uk)
SI (1) SI1699468T1 (uk)
UA (1) UA83516C2 (uk)
WO (1) WO2005049047A1 (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099867A1 (en) * 2005-05-24 2007-05-03 Glycoscience Laboratories, Inc. Pharmaceutical agent containing hyaluronan as an active ingredient
JP2007153761A (ja) * 2005-12-01 2007-06-21 Toshitsu Kagaku Kenkyusho:Kk シナプス伝達促進剤及びシナプス保護剤
RU2342148C2 (ru) * 2005-09-26 2008-12-27 Гликосайенс Лабораториз, Инк. Фармацевтическое средство, содержащее гиалуронан в качестве активного ингредиента
JP2009091248A (ja) * 2006-01-17 2009-04-30 Toshitsu Kagaku Kenkyusho:Kk 外傷性神経障害および／または運動機能障害の治療薬
BRPI0621470A2 (pt) 2006-12-05 2011-12-13 Glycoscience Lab Inc agente terapêutico para artrite degenerativa
JP2007277258A (ja) * 2007-06-20 2007-10-25 Toshitsu Kagaku Kenkyusho:Kk 炎症及び神経疾患の治療剤及び予防剤
EA019998B9 (ru) * 2009-08-20 2016-01-29 Йеда Рисерч Энд Дивелопмент Ко. Лтд. Терапия глатирамером ацетатом с низкой кратностью
CN111647100B (zh) * 2020-07-14 2022-03-01 山东华熙海御生物医药有限公司 一种高分子量透明质酸锌的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203372B (en) * 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
EP0852501B1 (en) * 1995-09-28 2004-12-01 Sangstat Medical Corporation Use of hyaluronic acid as an immunosuppressant
HU225991B1 (en) * 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
DE19721099C2 (de) * 1997-05-20 1999-12-02 Fumapharm Ag Muri Verwendung von Fumarsäurederivaten
JP2003089647A (ja) * 1999-03-10 2003-03-28 Takada Seiyaku Kk 関節性疾患治療剤
JP2001163789A (ja) * 1999-12-13 2001-06-19 Maruho Co Ltd マトリックスメタロプロテアーゼ阻害用医薬組成物
BG104880A (en) * 2000-10-24 2002-04-30 Иван ХРИСТОВ Medicamentous preparation for multiple sclerosis treatment
JP4234439B2 (ja) * 2001-03-15 2009-03-04 生化学工業株式会社 Ｉｌ−１２発現調節剤

Also Published As

Publication number Publication date
JP2007512311A (ja) 2007-05-17
HUP0303779D0 (en) 2004-03-01
PL1699468T3 (pl) 2007-09-28
ES2286698T3 (es) 2007-12-01
EP1699468A1 (en) 2006-09-13
EP1699468B1 (en) 2007-04-18
JP4778908B2 (ja) 2011-09-21
NO336121B1 (no) 2015-05-18
CN1882352A (zh) 2006-12-20
HRP20070291T3 (en) 2007-10-31
HUP0303779A2 (en) 2006-02-28
DK1699468T3 (da) 2007-09-03
NO20062857L (no) 2006-08-18
DE602004006024D1 (de) 2007-05-31
EA200600998A1 (ru) 2006-10-27
CY1106617T1 (el) 2012-01-25
CN1882352B (zh) 2010-08-04
RS20060325A (en) 2008-08-07
RS50523B (sr) 2010-05-07
UA83516C2 (uk) 2008-07-25
PT1699468E (pt) 2007-06-05
SI1699468T1 (sl) 2007-08-31
EA009209B1 (ru) 2007-12-28
ATE359800T1 (de) 2007-05-15
WO2005049047A1 (en) 2005-06-02
US20070123488A1 (en) 2007-05-31
DE602004006024T2 (de) 2007-12-27

Similar Documents

Publication Publication Date Title
MY143795A (en) Tetrahydropyridoindole derivatives
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
HK1098352A1 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
WO2005004818A3 (en) Heterocyclic compounds and their use as anticancer agents
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
HK1065483A1 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
UA96449C2 (en) Stable laquinimod preparations
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
TW200633978A (en) 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
DE602004011394D1 (en) Thiazolderivate
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
WO2007100758A3 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
WO2005092878A3 (en) Schweinfurthin analogues
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
PT1718651E (pt) Derivados 7h-pirrolopirimidina
MXPA05007253A (es) Sales novedosas de derivados anticonvulsivantes.
TNSN07283A1 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2005062874A3 (en) Compounds and compositions for delivering active agents
WO2005030785A3 (fr) Nouveaux composes du thioxylose, procede de preparation, compositions pharmaceutiques les contenant et leur utilisation en therapeutique

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191116